Johnson & Johnson
Big Business |
Consumer Products
Raynham, MA 02767-5199
Recent News About Johnson & Johnson
View More
-
DALLAS – Six plaintiffs reaped a combined $247 million in damages following a trial against Johnson & Johnson over an allegedly defective hip implant device.
-
HOUSTON – A federal jury has found that there was no defect in a pelvic mesh product when it left the possession of Ethicon, a subsidiary of Johnson & Johnson.
-
Christiaan Barnard performed the first heart transplant in 1967, just 50 years ago. Today, heart transplants are commonplace procedures, and artificial hearts and pacemakers also extend lives in ways medically impossible just a few decades ago. Transplants of other organs are now routine, too, as are the attachment of prosthetic limbs and the implantation of artificial joints.
-
DALLAS – Medicinal-pharmaceutical corporate giant Johnson & Johnson Co. continues to battle more than 8,000 lawsuits made against the company over an allegedly defective hip implant device, and attorneys for the firm insist they are in the right despite continuing setbacks in a case that seems to have no end.
-
DALLAS – DePuy Orthopaedics and Johnson & Johnson have appealed a trial court decision that would have them pay out $150 million in damages to five plaintiffs.
-
DALLAS – A verdict of more than $1 billion has been handed down by a federal jury in a lawsuit regarding hip replacements.
-
DALLAS -- Another verdict has been handed down in one of the cases against Johnson & Johnson and its subsidiary DePuy Orthopaedics Inc.
